Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from ...

“Best known as a trusted nausea remedy, ginger tea has a spicy and full-bodied flavour,” they said. “It contains the ...

This tea tea been used as a remedy for nausea, but its uses could go far beyond this as it is thought to have antioxidant and ...

This tea tea been used as a remedy for nausea, but its uses could go far beyond this as it is thought to have antioxidant and anti-inflammatory properties ...

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2025 ...

for ophthalmic diseases and anticoagulant Xarelto (rivaroxaban) in the coming years. Nubeqa is one of three drugs that the company is hoping will help it weather that impact on revenues ...

as it looks for a successor to Johnson & Johnson-partnered anticoagulant Xarelto (rivaroxaban), its biggest-selling drug which is facing the loss of patent protection in 2023. "The underlying ...